Vaccine-enhanced CAR-T cells produce large amounts of IFN-γ, thereby activating a large number of T cells, which work together to circumvent the escape of antigen-negative tumor cells, thereby achieving tumor cell eradication and preventing tumor regeneration [97]. The gene discussed is IFNG; the disease is neoplasm.